Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
BridgeBio Pharma: Fourth Quarter Financial Highlights

BridgeBio Pharma: Fourth Quarter Financial Highlights

101 finance101 finance2026/02/24 21:33
By:101 finance

BridgeBio Pharma Reports Fourth Quarter Financial Results

BridgeBio Pharma Inc., headquartered in Palo Alto, California, announced a net loss of $192.9 million for the fourth quarter.

This equates to a loss of $1 per share for the quarter.

The company’s performance did not meet analyst expectations, as the consensus among ten analysts surveyed by Zacks Investment Research had predicted a smaller loss of $0.75 per share.

Despite the loss, BridgeBio Pharma generated $154.2 million in revenue during the quarter, surpassing the $150 million anticipated by eight Zacks analysts.

Looking at the full year, BridgeBio Pharma’s net loss increased to $724.9 million, or $3.78 per share, with annual revenue totaling $502.1 million.

Since the start of the year, the company’s stock price has declined by 11%. However, by the close of trading on Tuesday, shares reached $68.31, reflecting an 88% increase over the past twelve months.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!